Previous studies have indicated that SPP1 is overexpressed in various cancers and can serve as a predictor of poor outcomes, including in ovarian cancer (10), glioblastoma (11), hepatocellular carcinoma (12), and gastric cancer (13). This evidence concerns the gene SPP1 and cancer.